Skip to main content
. Author manuscript; available in PMC: 2015 Jun 29.
Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2012 Dec 26;97(1):28–35. doi: 10.1002/bdra.23096

Figure 1.

Figure 1

Flow diagram showing study participation rates and exclusion criteria for mothers of case and control infants in the analyses of venlafaxine and birth defects, National Birth Defects Prevention Study, 1997–2007